Additionally, our data showed that 24F4A was able to inhibit IFNα from CpG-A, R848, and ssRNA stimulated PBMC from the cohort of CLE patients studied regardless of the presence of systemic disease (SLE) (Figure 5D). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.